TY - JOUR
T1 - Caught in the crossfire
T2 - cancer, cisplatin therapy, and kidney injury
AU - Humphreys, Benjamin D.
N1 - Funding Information:
Work in the Humphreys laboratory is supported by seed network Grant CZF2019-002430 from the Chan Zuckerberg Initiative and National Institute of Diabetes and Digestive and Kidney Diseases Grants DK103740 and UC2DK126024 (all to B.D.H.).
Funding Information:
B.D.H. is a consultant for Janssen Research & Development, LLC, Pfizer, and Chinook Therapeutics, holds equity in Chinook Therapeutics, and receives grant funding from Janssen Research & Development, LLC, and Pfizer; all interests are unrelated to the current work.
PY - 2023/4
Y1 - 2023/4
UR - http://www.scopus.com/inward/record.url?scp=85151043457&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.00037.2023
DO - 10.1152/ajprenal.00037.2023
M3 - Editorial
C2 - 36892907
AN - SCOPUS:85151043457
SN - 1931-857X
VL - 324
SP - F362-F363
JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
IS - 4
ER -